Hypertension Prevention in Pre-Hypertensive Individuals
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 730 participants.
Also called NCT00970931
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 730 participants
- Registry
-
NCT00970931
-
- Other papers using this trial's data
- Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial
- Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT00970931. Randomized; quadruple masking; primary purpose prevention. Start 2010-07 (registry gives no type); primary completion 2014-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hypertension Prevention in Pre-Hypertensive Individuals
- Acronym
- PREVER
- Condition
- Pre-hypertension
- Condition
- Hypertension
- Condition
- Cardiovascular Disease
- Intervention (Drug)
- Chlorthalidone plus amiloride
- Intervention (Drug)
- placebo
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Collaborator
- Financiadora de Estudos e Projetos
Record details
- Record id
cardio:ct-nct00970931- Content hash
6c9b46dcd6798cb7a8c060a0b1c0cb617d22ac5a395b7590dd80c767ca03d837